IPR National Ip Policy Evaluation.

23 Jan 2026 --
0 Comments

IPR TRIPS Compliance Review

1. Introduction

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), administered by the WTO, sets minimum standards for:

Copyrights

Patents

Trademarks

Industrial designs

Trade secrets and confidential information

TRIPS compliance is mandatory for all WTO members, requiring domestic laws to meet the minimum standards. Case laws across jurisdictions illustrate how TRIPS is implemented, interpreted, and enforced.

2. Key TRIPS Requirements

Patents – 20-year protection; non-discrimination for fields of technology

Copyrights – 50 years minimum post-author’s death; protection for digital works

Trademarks – Rights must be recognized for goods and services

Enforcement – Effective remedies: injunctions, damages, criminal liability

Exceptions – For public health, education, research

Dispute Settlement – WTO dispute resolution for TRIPS violations

3. Case Laws Demonstrating TRIPS Compliance

CASE 1: Novartis AG vs Union of India (2013)

Issue:

Patentability of a new form of an existing drug (Glivec) in India

TRIPS Aspect:

Article 27: Patent protection for all inventions (excluding exceptions)

Article 31: Compulsory licensing

Outcome:

Supreme Court of India rejected patent application due to lack of enhanced efficacy

Demonstrated TRIPS-compliant flexibility for public health

Lesson:

TRIPS allows countries to deny patents on minor modifications to prevent evergreening

CASE 2: India – US WTO Dispute on Pharmaceutical Patents (2007)

Issue:

Alleged non-compliance of India’s patent law with TRIPS for pharmaceuticals

Outcome:

WTO panel recognized India’s public health-oriented patent exceptions as TRIPS-compliant

India’s law permitted generic drug production under compulsory licensing

Lesson:

TRIPS compliance is flexible to protect public interest and health

CASE 3: Eli Lilly and Co v Canada (2017, Federal Court of Canada)

Issue:

Patent on incremental improvements in drugs

TRIPS Aspect:

Compliance with Article 27 – inventive step and novelty

Outcome:

Canadian courts rejected Eli Lilly’s “evergreening” claims

Courts emphasized high inventive threshold

Lesson:

TRIPS allows national discretion in defining patentability standards

CASE 4: Merck & Co vs Integra Life Sciences (US, 2005)

Issue:

Research exemption in patent law for pharmaceuticals

TRIPS Aspect:

Article 30 – limited exceptions to exclusive rights

Outcome:

US Supreme Court recognized research use exemption

Promotes innovation while maintaining TRIPS compliance

Lesson:

TRIPS permits exceptions for scientific research, innovation, and education

CASE 5: Microsoft v Motorola Mobility (UK & EU, 2014)

Issue:

FRAND licensing obligations for standard-essential patents (SEPs)

TRIPS Aspect:

Article 31 – patent licensing terms must be reasonable and non-discriminatory

Outcome:

Courts enforced reasonable royalty rates

Ensured compliance with TRIPS principles on licensing and competition

Lesson:

TRIPS requires enforcement mechanisms that balance IPR and fair competition

CASE 6: Apple Inc v Samsung Electronics (Global Jurisdictions)

Issue:

Design and utility patent infringement

TRIPS Aspect:

Article 9 (Copyright) and Article 10 (Computer programs) – protection for industrial designs and software

Outcome:

Courts in US, EU, and Asia awarded damages and injunctions

Demonstrates TRIPS-consistent enforcement of patents and designs internationally

Lesson:

TRIPS encourages harmonized cross-border IP enforcement

CASE 7: India – Natco Pharma vs Bayer Corp (2012)

Issue:

Compulsory license for Nexavar (cancer drug)

TRIPS Aspect:

Article 31 – compulsory licensing to address public health

Outcome:

Natco granted license to produce generic version at affordable price

Affirms TRIPS flexibility for access to medicines

Lesson:

TRIPS recognizes public interest and affordable access to essential drugs

4. Key Observations on TRIPS Compliance

Area	Observation	Case Reference
Patents & Public Health	Countries can deny patents or grant compulsory licenses	Novartis v India; Natco v Bayer
Research Exemption	Research and experimental use allowed	Merck v Integra
Patentability Standards	TRIPS allows national discretion	Eli Lilly v Canada
Licensing & FRAND	TRIPS-compliant enforcement of reasonable licensing	Microsoft v Motorola
Copyright & Digital Works	Protection of industrial designs, software, digital media	Apple v Samsung
WTO Dispute Resolution	TRIPS disputes can be settled internationally	India-US Pharma dispute

5. Conclusion

TRIPS establishes minimum standards, but allows national flexibility in key areas:

Public health

Research exemptions

Patentability thresholds

Case laws from India, US, UK, Canada, EU demonstrate how countries balance:

IP protection

Innovation incentives

Public interest

Takeaway: TRIPS compliance is not rigid. Countries can design IPR laws that promote innovation while ensuring public welfare, as seen in pharmaceutical, software, and design sectors.